clinicaltrials
Post Haste: Why pharma is giving up on UK trials | Jasmin Kaur
linkedin.com

Had a conversation with someone outside of healthcare recently who was shocked by how long it takes to run clinical trials in the U.S (not to mention expensive).
I tried to explain—it’s not just the science. It’s the infrastructure. Every site needs dozens of personnel, many of whom are required by regulatory frameworks... See more
